Invesco Ltd. Buys 15,945 Shares of Privia Health Group, Inc. $PRVA

Invesco Ltd. raised its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 4.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 389,784 shares of the company’s stock after acquiring an additional 15,945 shares during the period. Invesco Ltd. owned about 0.32% of Privia Health Group worth $8,751,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of PRVA. CWM LLC lifted its stake in Privia Health Group by 50.3% during the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock valued at $40,000 after acquiring an additional 604 shares in the last quarter. Bessemer Group Inc. lifted its stake in Privia Health Group by 2,393.4% during the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company’s stock valued at $51,000 after acquiring an additional 2,178 shares in the last quarter. GAMMA Investing LLC lifted its stake in Privia Health Group by 113.1% during the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock valued at $64,000 after acquiring an additional 1,521 shares in the last quarter. Financial Management Professionals Inc. lifted its stake in Privia Health Group by 28.7% during the 1st quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company’s stock valued at $76,000 after acquiring an additional 754 shares in the last quarter. Finally, Vestcor Inc bought a new position in Privia Health Group during the 1st quarter valued at $76,000. 94.48% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have weighed in on PRVA. Barclays raised their price objective on Privia Health Group from $23.00 to $24.00 and gave the company an “equal weight” rating in a research note on Tuesday, May 27th. Piper Sandler decreased their target price on Privia Health Group from $36.00 to $35.00 and set an “overweight” rating for the company in a research report on Monday, August 11th. Evercore ISI decreased their target price on Privia Health Group from $30.00 to $28.00 and set an “outperform” rating for the company in a research report on Wednesday, July 9th. JPMorgan Chase & Co. raised their target price on Privia Health Group from $29.00 to $32.00 and gave the company an “overweight” rating in a research report on Wednesday, May 28th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $29.00 target price on shares of Privia Health Group in a research report on Monday, April 28th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $28.00.

Privia Health Group Stock Performance

Shares of PRVA opened at $21.99 on Monday. The business has a 50-day moving average of $20.94 and a 200 day moving average of $22.70. Privia Health Group, Inc. has a fifty-two week low of $16.47 and a fifty-two week high of $26.09. The firm has a market cap of $2.70 billion, a P/E ratio of 199.93, a price-to-earnings-growth ratio of 3.19 and a beta of 0.80.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.03). Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.The firm had revenue of $521.15 million during the quarter, compared to analysts’ expectations of $466.97 million. During the same period last year, the business posted $0.19 EPS. The company’s revenue was up 23.4% compared to the same quarter last year. Privia Health Group has set its FY 2025 guidance at EPS. As a group, research analysts predict that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.